BidaskClub Lowers Sinovac Biotech (SVA) to Hold


Separately, ValuEngine upgraded Sinovac Biotech from a "sell" rating to a "hold" rating in a research report on Friday, June 30th. Shares of NASDAQ SVA traded down $0.13 during mid-day trading on Wednesday, hitting $8.24.



from Biotech News